BG20583A3 - Метод за получаване на 2,6-диамино-дихидропиридини - Google Patents

Метод за получаване на 2,6-диамино-дихидропиридини

Info

Publication number
BG20583A3
BG20583A3 BG024472A BG2447273A BG20583A3 BG 20583 A3 BG20583 A3 BG 20583A3 BG 024472 A BG024472 A BG 024472A BG 2447273 A BG2447273 A BG 2447273A BG 20583 A3 BG20583 A3 BG 20583A3
Authority
BG
Bulgaria
Prior art keywords
dihydropyridines
diamino
preparation
Prior art date
Application number
BG024472A
Other languages
Bulgarian (bg)
English (en)
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG20583A3 publication Critical patent/BG20583A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BG024472A 1972-03-06 1973-02-28 Метод за получаване на 2,6-диамино-дихидропиридини BG20583A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BG20583A3 true BG20583A3 (bg) 1975-12-05

Family

ID=5838037

Family Applications (2)

Application Number Title Priority Date Filing Date
BG022858A BG22815A3 (bg) 1972-03-06 1973-02-28 Метод за получаване на 2,6-диамино-дихидропиридини
BG024472A BG20583A3 (bg) 1972-03-06 1973-02-28 Метод за получаване на 2,6-диамино-дихидропиридини

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG022858A BG22815A3 (bg) 1972-03-06 1973-02-28 Метод за получаване на 2,6-диамино-дихидропиридини

Country Status (24)

Country Link
JP (2) JPS5626659B2 (ja)
KR (1) KR780000119B1 (ja)
AT (3) ATA925774A (ja)
BE (1) BE796279A (ja)
BG (2) BG22815A3 (ja)
CA (1) CA988524A (ja)
CH (2) CH577473A5 (ja)
CS (2) CS182781B2 (ja)
DD (1) DD106833A5 (ja)
DE (1) DE2210687C3 (ja)
DK (1) DK136061C (ja)
ES (1) ES412323A1 (ja)
FI (1) FI55996C (ja)
FR (1) FR2181789B1 (ja)
GB (1) GB1379005A (ja)
HU (1) HU167089B (ja)
IE (1) IE37370B1 (ja)
IL (1) IL41664A (ja)
LU (1) LU67147A1 (ja)
NL (1) NL7303137A (ja)
PL (2) PL92078B1 (ja)
RO (2) RO63068A (ja)
SE (1) SE384208B (ja)
ZA (1) ZA731501B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (ja) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
CH580589A5 (ja) 1976-10-15
SE384208B (sv) 1976-04-26
ZA731501B (en) 1973-11-28
CA988524A (en) 1976-05-04
KR780000119B1 (en) 1978-04-15
ES412323A1 (es) 1976-01-01
DE2210687A1 (de) 1973-09-20
FI55996B (fi) 1979-07-31
DE2210687B2 (de) 1980-09-04
IE37370B1 (en) 1977-07-06
BG22815A3 (bg) 1977-04-20
FR2181789B1 (ja) 1976-12-03
JPS48103579A (ja) 1973-12-25
CH577473A5 (ja) 1976-07-15
RO61192A (ja) 1976-09-15
IL41664A (en) 1976-01-30
NL7303137A (ja) 1973-09-10
JPS5911584B2 (ja) 1984-03-16
HU167089B (ja) 1975-08-28
LU67147A1 (ja) 1973-05-22
DK136061C (da) 1978-01-02
RO63068A (ja) 1978-05-15
CS182781B2 (en) 1978-05-31
AT324338B (de) 1975-08-25
BE796279A (fr) 1973-09-05
FR2181789A1 (ja) 1973-12-07
AT327904B (de) 1976-02-25
GB1379005A (en) 1975-01-02
DD106833A5 (ja) 1974-07-05
IL41664A0 (en) 1973-05-31
DE2210687C3 (de) 1981-09-24
JPS5626659B2 (ja) 1981-06-19
ATA925774A (de) 1975-05-15
DK136061B (da) 1977-08-08
FI55996C (fi) 1979-11-12
IE37370L (en) 1973-09-06
PL92078B1 (ja) 1977-03-31
PL89256B1 (ja) 1976-11-30
JPS5699460A (en) 1981-08-10
CS182792B2 (en) 1978-05-31

Similar Documents

Publication Publication Date Title
BG22827A3 (bg) Метод за получаване на 1,2,4-триазол-нуклеозиди
IT978445B (it) Metodo per la preparazione di ammidosilani
BG20792A3 (bg) Метод за получаване на /2/ фурил - метил/ 6,7 бензоморфани
SU474150A3 (ru) Способ получени производных окса-1-диаза-3,8-спиро-(4,5)-декана
BG20336A3 (bg) Метод за получаване на 3-карбомоил-2.4.6- трийдефинил-алкилетери
BG17560A3 (bg) Метод за получаане на 4,20, 22- буфатриеноли- драмнозид- етери
BG20595A3 (bg) Методл за получаване на n-бензхидрил n-р-хидроксилбензил-пиперазини
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
BG19375A3 (bg) Метод за получаване на 3,4-1н-изохиномин-1-они
SE398750B (sv) Forfarande for framstellning av metylamino-2-metyl-4'-piperazinyl-4-klor-6-metyltio-5-pyrimidin
BG20583A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
FI52735C (fi) Menetelmä uusien pregnadieeni-21-happojohdannaisten valmistamiseksi.
AR198695A1 (es) Metodo para preparar 2-sustituido-4-hidroxiclopentano 1, 3-dionas
RO69492A2 (ro) Procedeu pentru prepararea perclor-metil-mercaptanului
BG25985A3 (bg) Метод за получаване на 13 бета-етил-17 d-етинил-гон- -4-еп-3-он-17 бета-ол
AR202805A1 (es) Metodo para la preparacion de tiaxantenos, fluor-substituidos
SE415475B (sv) Forfarande for framstellning av 4,5-didehydro-pgf?711alfa
AR193078A1 (es) Metodo para la preparacion de 2,4-diamino-bencilpirimidinas
DK131855C (da) Fremgangsmade til fremstilling af 3,4-dihydropyridoner
BG20795A3 (bg) Метод за получаване на триазинобензимидазоли
BG19803A3 (bg) Метод за получаване на 4-или-5-нитроимидазоли
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
IT997894B (it) Procedimento per la produzione di 2.cloropiridina
SU457695A1 (ru) Способ получени -аминопропионитрила
SE396389B (sv) Forfarande for framstellning av 2-karboxi-4-oxo-4h, 10h-(2)-bensopyrano-/4,3-g/-(1)-bensopyraner